Free Trial
→ There is a little known company that is changing warfare (From Reticulate) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 15 of 15

Slide 15
Back to 14
Next Slideshow
 
Back to 14
Next Slideshow
 

Vaxcyte (NASDAQ:PCVX)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$147.50 (69.9% Upside)

About Vaxcyte

Vaxcyte logoVaxcyte, Inc, a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/6/2024Cantor FitzgeraldReiterated RatingOverweight
11/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$140.00 ➝ $140.00
9/10/2024MizuhoBoost Price TargetOutperform ➝ Outperform$113.00 ➝ $163.00
9/4/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$101.00 ➝ $140.00
9/3/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$108.00 ➝ $129.00
9/3/2024Leerink PartnersBoost Price TargetOutperform ➝ Outperform$106.00 ➝ $153.00
9/3/2024BTIG ResearchBoost Price TargetBuy ➝ Buy$98.00 ➝ $160.00
9/3/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$95.00 ➝ $140.00
8/7/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$95.00 ➝ $95.00
6/28/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$95.00 ➝ $95.00

More Investing Slideshows:

Slide 15
Back to 14
Next Slideshow
 

There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

More From MarketBeat
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
7 Best Chinese Stocks to Own Before the Bubble Bursts
The geopolitical relationship between the United States and China is volatile and complicated. But the importa...
MarketBeat
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored
The Top-Rated Dividend Stocks for 2023
MarketBeat tracks approximately 250,000 analyst recommendations each year and tracks more than 15,000 securiti...
MarketBeat
[Urgent] Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...
Paradigm Press | Sponsored
15 Stocks That Insiders Won't Stop Buying
An insider trade occurs when a corporate executive (such as a CEO, CFO or COO) that has non-public information...
MarketBeat